Impact Of Rebates On Drug Pricing Will Diminish -- CMS Experts
Executive Summary
Actuaries with the US Centers for Medicare and Medicaid Services predict the share of retail prescription drug costs represented by manufacturer rebates will level off in the coming years, resulting in higher drug pricing trends across government and commercial insurance.